²³´´µ b+3¶ + ·
+3¸,+
19
,**+
ῌ The effect of parathyroid function on cardiovascular disease of
maintainance dialysis patients
KANEKO Tetsuya, KITAMURA Hiroshi, MIZUI Masayuki, MATSUI Isao,
YAMAMOTO Satoshi, FUJITA Yoshimasa and FUJII Masamitsu
Key words : &|1-'{jY - D x}?~€z1
-'{jY . D CaP 12"!E#="j
!
Y ‚ƒF„3J…J…34F/%@A!†
!"#$%&'()*"+#,-.!$ῌ/
1,#="Y‡G7U;:'Tˆ34'5 ˆ‰
%&012'34'5 63
7
631,Š'7
78(19:;<='5 >
19:; Rostand SG ZHI+D ,-.
?@A BC PTHD E)* + +F3 GH!
Geoffrey ZHI,D jkJH(K‹T4'5 GH
IJK;LM&'5
ZoApqg?@A!LŒU;:
,-.,-.N JO/
'63<@&="34'5
P!0Q;:'R!SQ;
63M z1Ž&E
PTH B1 intact῍PTHD 12T3'34'5 ) !0Q(,-.
14U; V5W
"7/% N‘U;:'
X6YZ[?\%7!]^_`abcA D 8
1Ž&’“19:;LMU
9 d:;ebfg?<=%7 BPEITD (:5
>hi BPTXD jkTlmnH PTH ?ToAp
qg?nH;:'5 UYU
YZr
+4 ῌ
63oApqg?&=" PTH @A?19:;
+ D 1Ž&’“
oAsAt\TBZH;:j:5 *u
,-.1,:; PTH ”•O
1-'vw + D PTH CDE)j
Ca –—APQu˜E)1-FcpoA™yš
, D xyAzjk!{(Z
ATP ›!RSUœ;1žŸ T
Y
*+
,-.1,Š'¡¢j PTH z14&'E)
ῌV £ Ca PzU¤Vh
ῌz¥ £ ¦893§ ;893u˜
ῌžŸ £ ¦893N‘ UYU”cpoA™yš ATP ›!"(UW¨;1
ῌ”•O £ •O Ca N‘ ”X ”©ªY«¬
ῌ*Z £ y­[\5W®0 –A\yA]¯ z^°”•O Ca N‘ z_±¬ ”_±¬ `a_±¬
³´µ¶¶£ ¤+3· + ¸
20
PTX _`3
…Y* ^EF%a
†
bACc3‡&
*/ˆ
PTX KL^EF&;%*JyDyE‰Š 56de‹
!"#$%
&
*3456%sF G0
"&
'()
*+ ,-
%&
ŒEBCT2 a†
#1(
PTH !$. / !0%"
yDyE‰Šhijk&
&
electronῌbeam
computed
tomography
fg*J
,5 022
#1&
-5 .2 %
#1-
Johann *^EF
"#%34
&;%0l T5Ž*emn
5
, 2 56789:
9JE|M 59jA PTH ‘{E*em
'56*$%&;%'<(
sV
02 ’o Raggi * Ca
=56&;%*'(
>)
?P // mg,ῌdl, pq &;
&;%*+ PTH ,-./ Ca
% 56“rs( it' uv
?P @ABCDE
./<
j”•w
F
12 Geof-
F G056&;%*1H>)
frey *59JE|M 34,340 mgῌdl 59j
&;%*+IJKLM*"2N
A ,4//4/ mgῌdl Ca?P // mg,ῌdl, wx
yF iῌPTH ‡ +**,**
34O*56 P&;%Q *RID
S56T Ca 5 T P 5UV
pgῌml @ABCDEF&
,2
Goodman *z–0l+3— 1 ˜<{'
WF
PmetastaticQ % 7X8Y5
( ŒN™,-2 ‰| 0l š/ 59 P }
659 Ca 59 P :;FWF
~ Ca?P 3 Ca €‚T'^EF
PdystrophicQ % , <=&
&;%n
22 ƒ›#1*
3>>)&;%* PmetastaticQ (Mœ&
59 P 59 Ca PTH Ca?
?@
Geoffray *56Z
P O„<F
=p:;
&;%*[\AB]=
CD
(^EF&;%59+5,/ῌžzŸA D
,2 =^EF_`%Ga*bc.
}~#…e#1&!32 '(
H%<
.Id
#1&!b%
†.‰|‡=
EBCT ¡+G
=J?&;%WF
"&
(ˆ‰‰¢£¤jJE CT ^EF€a†
/2
KL#1 !^EF&;%*M,
Š-¥
ijk‰Š
59 Ca 59 P Ca?P PTH eN&!
* ^EF‹9Œ“¦[~Ž3=
fOPF
=Q + 
s<§‘~’“[¨”fs
2 < PTH * Ca P RS-HT
•–—*©
ª˜
g9:&
hU PTH * Hepatic tri-
š™
glyceride lipase ( i lipoprotein lipase V
, 2 $3
X !59Bjkjlmno,- LDL W
'š
)*T5Ž ›5 p
p HDL qM 'r
l œ§ >; «¬­z®>; s!,3>EF_`%tN
4u
tN
/ !0%
&
* ,X
= PTH $. ¡$&;%#1
YZ>;EF`%eN
Rostand *$&;% PTH *…e
*n Ca?P *…e&V
,4 !"#
+ 2 ^EF3
,v <'^EF3
+*2 ,^EF€3 ¯5
%žt' ŽŸ°p…V
'$3
- 2 t'
&;%3(&w
*i=
Braun *,2˜s12˜='.3 ¡
x[,`3(,JyDyEnAzD{A
Š/3±¢8<&;% //±EF
|}A\]~^( ^EF&;%*1
&;%-#1
’^EF&
H€3'<*H=‚$ƒ„
;%”@²EF&;%*…e&V
µ¶c · ῌd7QRS¸œ-)KL*%®¯
21
0 minD^ D‚WDƒ„^ ©ª\V«©¬@8
CaP Al Z[M,6 6^_
++ !"#
)KL*%LŽJO%­)®¯
$%&'()*+
fg
hCWmn'^ °)KL
,-.'!&*+
*%LŽ9FB±OJ
. /
0
12)3*45
6,-7 !89&':
;)<=> ?@ABC@DE@"#
3F9G)$%3&'(
H9)I#<= J=*)KL*
%+,6-9MN'
9<=!&
*+ .OP!/01QRS
2))KL*%T@UVBWX
>
Y/T@Z@[\3,4> ]
5 Ca^ ]5 P^ CaP T@UVBW9_`a
)KL* PEIT^ PTX %9b6cd
7+eP 4fghCW*iA
j@ D 8 PTH 9:;<9k%lJ
mn%lopq9r=cd7s
t uLvw PTH >?x.
O;<
@'O+oiAj@ D 8
yAzmn*OI#<=>
{0&'iAj@ D |}8]~
9BcOC€"#*+ 4D
‚WDƒ„E…† P ]‡T@UVBW
† Ca ]‡9Fd7+a Ca 9ˆ4
P ‰G…OŠH‹n*ŒI`a
>>T@UVBW)!&J
JhCWK>
'<=>
-4 )KL*%LŽ‡o]~M,
<=>B\N) Kruz >
LbOy‡P*y Ca ‘’“”BQ
•'|} Ca 82–—˜^ ]5 Ca R
S™še›)d79+, )KL*
%LŽyAzbOLŽœo^ y
Ca, P ‘’“”B%LŽL
*^ ‚WDƒ„E…^ iAj@ D 8^ Tž
6]5 Ca ™še›œ^ UV
WX2Ÿ*&5 ¡eP ¢metastatic£ %lY]~œo<
=>
)KL*%LŽH‡^ ¤Wj¥ƒ„Z
[ ^ † ^ ?\^ CAPD^ ]… ¦ §7¨ Vita-
²`™a<=> ³8^ )KL*%LŽ
œ-]~-´KFb
+ Rostand SG, Drueke TB : Parathyroid hormone,
vitamin D, and cardiovascular disease in chronic
renal failure : Kidney Int, /0 ; -2-, +333.
, Geoffrey A, Block MD, et al : Reῌevaluation of
risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients : Recommendations for a change in management, Am J
Kidney Dis, -/ ; +,,0, ,***.
- Simons C, Fortune F, Greenbaum RA et al : Cardiac hypertrophy, hypertrophic cardiomyopathy
and hyperparathyroidismῌan association : Br Heart
J, /. ; /-3, +32/.
. Mall G, et al : Myocardial interstitial fibrosis in
experiment uremiaῌimplication for cardiac complicance. Kidney Int, -- ; 2*., +322.
/ Wexler L, et al : Coronary artery calcification :
Pathophysiology, epidemiology, imaging methods
and clinical implications : A statement for health
professionals from American Heart Association :
Circulation, 3. ; ++1/, +330.
0 Johann et al : Electron beam computed tomography in the evaluation of cardiac calcifications in
chronic dialysis patients : Am J Kidney Dis, ,1 ;
-3., +330.
1 Raggi P : Detection and quantitification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients :
Clin Nephrol, /. ; -,/, ,***.
2 Goodman WG et al : Coronaryῌartery calcification in young adults with endῌstage renal disease
who are undergoing dialysis : N Engl J Med, -., ;
+.12, ,***.
3 Karol E, Walton, MD et al : Active serum vitamin D levels are inversely corrected with coronary calcification. Circulation 30 ; +1//, +331.
+* Rostand SG, et al : Myocardial calcification and
cardiac dysfunction in chronic renal failure : Am J
Med, 2/ ; 0/+, +322.
++ Ribeiros et al : Cardiac valve calcification in haemodialysis patients : role of calciumῌphosphate
metabolism : Nephrol Dial Transplant +- ; ,*-1, +332.
+, Kurz P et al : Evidence for abnormal calcium
homeostasis in patients with adynamic bone disease : Kidney Int, /0 ; 2//, +33..

A Delayed Emergence from Anesthesia after a Small Dose of Fentanyl